Annual Net Income
-$2.16 M
+$5.56 M+72.04%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual net profit is -$2.16 million, with the most recent change of +$5.56 million (+72.04%) on December 1, 2023.
- During the last 3 years, XRTX annual net income has fallen by -$1.15 million (-114.22%).
- XRTX annual net income is now -7215.59% below its all-time high of -$29.50 thousand, reached on February 1, 2015.
Performance
XRTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$587.00 K
-$757.10 K-445.09%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly net profit is -$587.00 thousand, with the most recent change of -$757.10 thousand (-445.09%) on September 1, 2024.
- Over the past year, XRTX quarterly net income has dropped by -$3.29 million (-121.75%).
- XRTX quarterly net income is now -108.57% below its all-time high of $6.85 million, reached on December 1, 2021.
Performance
XRTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$736.60 K
+$746.40 K+50.33%
September 1, 2024
Summary
- As of February 7, 2025, XRTX TTM net profit is -$736.60 thousand, with the most recent change of +$746.40 thousand (+50.33%) on September 1, 2024.
- Over the past year, XRTX TTM net income has increased by +$1.42 million (+65.87%).
- XRTX TTM net income is now -143.17% below its all-time high of $1.71 million, reached on September 30, 2022.
Performance
XRTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
XRTX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +72.0% | -121.8% | +65.9% |
| 3 y3 years | -114.2% | +68.0% | +89.2% |
| 5 y5 years | +22.1% | +68.0% | +89.2% |
XRTX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.6% | +72.0% | -108.6% | +80.6% | -143.2% | +90.5% |
| 5 y | 5-year | -347.7% | +72.0% | -108.6% | +91.0% | -143.2% | +91.7% |
| alltime | all time | -7215.6% | +72.0% | -108.6% | +91.0% | -143.2% | +91.7% |
XORTX Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$587.00 K(-445.1%) | -$736.60 K(-50.3%) |
| Jun 2024 | - | $170.10 K(-105.6%) | -$1.48 M(-55.7%) |
| Mar 2024 | - | -$3.02 M(-211.8%) | -$3.35 M(+55.0%) |
| Dec 2023 | -$2.16 M(-72.0%) | $2.70 M(-302.4%) | -$2.16 M(-71.0%) |
| Sep 2023 | - | -$1.33 M(-21.2%) | -$7.44 M(+1.9%) |
| Jun 2023 | - | -$1.69 M(-7.6%) | -$7.30 M(+6.6%) |
| Mar 2023 | - | -$1.83 M(-29.0%) | -$6.85 M(-11.3%) |
| Dec 2022 | -$7.72 M(+388.8%) | -$2.58 M(+115.4%) | -$7.72 M(-552.4%) |
| Sep 2022 | - | -$1.20 M(-3.4%) | $1.71 M(-146.8%) |
| Jun 2022 | - | -$1.24 M(-54.2%) | -$3.65 M(+41.1%) |
| Mar 2022 | - | -$2.70 M(-139.5%) | -$2.58 M(+61.3%) |
| Dec 2021 | -$1.58 M(+56.8%) | - | - |
| Dec 2021 | - | $6.85 M(-204.5%) | -$1.60 M(-81.9%) |
| Sep 2021 | - | -$6.55 M(+3617.3%) | -$8.83 M(+239.6%) |
| Jun 2021 | - | -$176.20 K(-89.8%) | -$2.60 M(-3.6%) |
| Mar 2021 | - | -$1.72 M(+346.2%) | -$2.70 M(+169.8%) |
| Dec 2020 | -$1.01 M(+109.0%) | -$385.90 K(+21.6%) | -$1.00 M(+30.9%) |
| Sep 2020 | - | -$317.40 K(+16.0%) | -$763.90 K(+39.9%) |
| Jun 2020 | - | -$273.60 K(+1069.2%) | -$546.10 K(+39.7%) |
| Mar 2020 | - | -$23.40 K(-84.3%) | -$390.90 K(-0.4%) |
| Dec 2019 | -$482.00 K | -$149.50 K(+50.1%) | -$392.40 K(+89.7%) |
| Sep 2019 | - | -$99.60 K(-15.9%) | -$206.80 K(-40.0%) |
| Jun 2019 | - | -$118.40 K(+375.5%) | -$344.70 K(-20.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$24.90 K(-169.0%) | -$435.30 K(-84.3%) |
| Dec 2018 | -$2.77 M(+635.2%) | $36.10 K(-115.2%) | -$2.77 M(-8.8%) |
| Sep 2018 | - | -$237.50 K(+13.6%) | -$3.04 M(+3.9%) |
| Jun 2018 | - | -$209.00 K(-91.1%) | -$2.92 M(+6.3%) |
| Mar 2018 | - | -$2.36 M(+1087.3%) | -$2.75 M(+325.8%) |
| Dec 2017 | -$377.10 K(+17.3%) | -$198.70 K(+543.0%) | -$645.30 K(+44.5%) |
| Nov 2017 | - | -$30.90 K(-56.0%) | -$446.60 K(-2.6%) |
| Sep 2017 | - | -$70.20 K(+30.7%) | -$458.50 K(+18.1%) |
| Aug 2017 | - | -$53.70 K(+52.6%) | -$388.30 K(+3.7%) |
| May 2017 | - | -$35.20 K(-29.0%) | -$374.40 K(+0.3%) |
| Mar 2017 | - | -$49.60 K(-76.0%) | -$373.10 K(+15.3%) |
| Feb 2017 | -$321.50 K(+4.2%) | -$207.00 K(+383.6%) | -$323.50 K(+210.2%) |
| Dec 2016 | -$308.60 K(+104.4%) | - | - |
| Nov 2016 | - | -$42.80 K(+7.5%) | -$104.30 K(-27.1%) |
| Aug 2016 | - | -$39.80 K(+17.4%) | -$143.10 K(+3.3%) |
| May 2016 | - | -$33.90 K(-377.9%) | -$138.50 K(-10.6%) |
| Feb 2016 | -$151.00 K(+411.9%) | $12.20 K(-115.0%) | -$155.00 K(-13.7%) |
| Nov 2015 | - | -$81.60 K(+131.8%) | -$179.70 K(+73.3%) |
| Aug 2015 | - | -$35.20 K(-30.2%) | -$103.70 K(+39.0%) |
| May 2015 | - | -$50.40 K(+303.2%) | -$74.60 K(+147.8%) |
| Feb 2015 | -$29.50 K | -$12.50 K(+123.2%) | -$30.10 K(+71.0%) |
| Nov 2014 | - | -$5600.00(-8.2%) | -$17.60 K(+46.7%) |
| Aug 2014 | - | -$6100.00(+3.4%) | -$12.00 K(+103.4%) |
| May 2014 | - | -$5900.00 | -$5900.00 |
FAQ
- What is XORTX Therapeutics annual net profit?
- What is the all time high annual net income for XORTX Therapeutics?
- What is XORTX Therapeutics annual net income year-on-year change?
- What is XORTX Therapeutics quarterly net profit?
- What is the all time high quarterly net income for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly net income year-on-year change?
- What is XORTX Therapeutics TTM net profit?
- What is the all time high TTM net income for XORTX Therapeutics?
- What is XORTX Therapeutics TTM net income year-on-year change?
What is XORTX Therapeutics annual net profit?
The current annual net income of XRTX is -$2.16 M
What is the all time high annual net income for XORTX Therapeutics?
XORTX Therapeutics all-time high annual net profit is -$29.50 K
What is XORTX Therapeutics annual net income year-on-year change?
Over the past year, XRTX annual net profit has changed by +$5.56 M (+72.04%)
What is XORTX Therapeutics quarterly net profit?
The current quarterly net income of XRTX is -$587.00 K
What is the all time high quarterly net income for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly net profit is $6.85 M
What is XORTX Therapeutics quarterly net income year-on-year change?
Over the past year, XRTX quarterly net profit has changed by -$3.29 M (-121.75%)
What is XORTX Therapeutics TTM net profit?
The current TTM net income of XRTX is -$736.60 K
What is the all time high TTM net income for XORTX Therapeutics?
XORTX Therapeutics all-time high TTM net profit is $1.71 M
What is XORTX Therapeutics TTM net income year-on-year change?
Over the past year, XRTX TTM net profit has changed by +$1.42 M (+65.87%)